12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Monday's intraday session, with NRX Pharmaceuticals, TC BioPharm, Outset Medical, Nanoviricides, Chemomab Therapeutics, and Titan Pharma among the gainers. Conversely, Lyra Therapeutics, GlycoMimetics, EyePoint Pharmaceuticals, Acutus Medical, Integra Lifesciences, and Helius Medical Technologies were notable losers. The movements were attributed to various factors, including earnings reports for some companies.
May 06, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Integra Lifesciences shares declined 20.46% to $22.98, with a market cap of $1.8 billion, as its Q1 earnings were released today.
The decline in IART's stock price following its Q1 earnings release indicates a negative investor response, likely due to disappointing earnings results.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Lyra Therapeutics shares plummeted 86.3% to $0.55, with a market cap of $33.6 million, following its Q1 earnings report.
The drastic decline in LYRA's stock price post-earnings suggests a negative market reaction to its financial performance, indicating a bearish outlook in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
POSITIVE IMPACT
NRX Pharmaceuticals shares surged 39.5% to $2.93, with a market cap of $30.9 million.
The significant increase in NRXP's stock price could attract investor interest, potentially leading to short-term price volatility.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90